Attenuation of Recombinant Vesicular Stomatitis Virus-Human Immunodeficiency Virus Type 1 Vaccine Vectors by Gene Translocations and G Gene Truncation Reduces Neurovirulence and En...

por Cooper, David, Wright, Kevin J., Calderon, Priscilla C., Guo, Min, Nasar, Farooq, Johnson, J. Erik, Coleman, John W., Lee, Margaret, Kotash, Cheryl, Yurgelonis, Irene, Natuk, Robert J., Hendry, R. Michael, Udem, Stephen A., Clarke, David K.
Publicado em 2008

A novel approach to generate a recombinant toxoid vaccine against Clostridium difficile

por Donald, Robert G. K., Flint, Mike, Kalyan, Narender, Johnson, Erik, Witko, Susan E., Kotash, Cheryl, Zhao, Ping, Megati, Shakuntala, Yurgelonis, Irina, Lee, Phillip Kwok, Matsuka, Yury V., Severina, Elena, Deatly, Anne, Sidhu, Mini, Jansen, Kathrin U., Minton, Nigel P., Anderson, Annaliesa S.
Publicado em 2013

Neurovirulence and Immunogenicity of Attenuated Recombinant Vesicular Stomatitis Viruses in Nonhuman Primates

por Clarke, David K., Nasar, Farooq, Chong, Siew, Johnson, J. Erik, Coleman, John W., Lee, Margaret, Witko, Susan E., Kotash, Cheryl S., Abdullah, Rashed, Megati, Shakuntala, Luckay, Amara, Nowak, Becky, Lackner, Andrew, Price, Roger E., Little, Peter, Kalyan, Narender, Randolf, Valerie, Javadian, Ali, Zamb, Timothy J., Parks, Christopher L., Egan, Michael A., Eldridge, John, Hendry, Michael, Udem, Stephen A.
Publicado em 2014